The latest news & events
Keep up to date with company updates, industry news, investor
press releases and event information.
Kneat Signs Global Biopharma Leader
LIMERICK, Ireland December 11, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that it has signed a five-year master service agreement with another of the world’s leading biopharmaceutical companies. This US headquartered company has over 10,000 employees and operations
Read More
Kneat Reports Third Quarter Results
LIMERICK, Ireland, November 26, 2019 /CNW/ – kneat.com, inc. (TSXV: KSI) (“Kneat”) today announced its financial results for the quarter ended September 30, 2019. All dollar amounts are presented in Canadian dollars unless otherwise stated. Third Quarter Highlights Revenue of $1,586,033 was
Read More
Big Pharma selects Kneat’s SaaS Platform for Digitalization of its Validation Work Processes
LIMERICK, Ireland November 25, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that it has signed a five-year master service agreement with another one of the worlds largest pharmaceutical companies, to digitalize key validation processes across its manufacturing sites.
Read More
Kneat Sponsors ISPE Greater Los Angeles Chapter Conference
Data Integrity ISPE LA 2019, December 05, Los Angeles, USA Data Integrity ISPE LA 2019, takes place on December 5th…
Read More
Kneat to exhibit at ManuPharma 2019
ManuPharma 2019, December 03-04, Frankfurt ManuPharma 2019, takes place on December 3rd – 4th in Frankfurt, Germany ManuPharma is firmly…
Read More
Kneat Appoints New Chief Financial Officer
LIMERICK, Ireland September 20, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat or the company”) today announced that it has appointed Mr. Hugh Kavanagh as its Chief Financial Officer effective September 23, 2019 following the resignation of Ms. Sarah Oliver who will assist in the transition. Mr.
Read More
Big Pharma selects Kneat’s Commissioning, Qualification and Validation platform
LIMERICK, Ireland September 17, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that it signed a three-year contract with one of the worlds largest pharmaceutical companies to enable digital transformation for its many validation work processes.
Read More
Kneat Reports Second Quarter Results
LIMERICK, Ireland, Aug. 27, 2019 /CNW/ – kneat.com, inc. (TSXV: KSI) (“Kneat”) today announced its financial results for the quarter ended June 30, 2019. All dollar amounts are presented in Canadian dollars unless otherwise stated. Second Quarter Highlights Revenue of $528,812 was recognized
Read More
August 20, 2019 | FDA to Close Public Consultation on ICH M10 Bioanalytical Method Validation
The US Food and Drug Administration (FDA) public consultation of the International Council for Harmonisation (ICH) draft guideline, M10 Bioanalytical…
Read More
Kneat to exhibit at KenX CSV and Data Integrity in Cork this November
KenX CSV and Data Integrity Inspection Readiness, November 25-27, Cork KenX Computer System Validation and Data Integrity Inspection Readiness, takes…
Read More
Global CDMO partners with Kneat to Digitize their Validation work Processes
LIMERICK, Ireland July 22, 2019 /CNW/ – kneat.com, inc. (TSX-V: KSI) (“Kneat”) is pleased to announce that a global contract development and manufacturing organization (“CDMO”) has selected Kneat’s platform to digitize their commissioning, qualification and validation work processes.
Read More
Kneat to support 2019 ISPE Europe Pharma 4.0
2019 ISPE Europe Pharma 4.0 Conference, November 20-21, Manchester 2019 ISPE Europe Pharma 4.0 Conference, takes place on November 20th…
Read MoreContact
Talk to us
Find out how Kneat can make your validation easier, faster, and smarter.
Start your paperless validation revolution by speaking to our experts.